Nutex Health is trading 5.04% up at $210.32, continuing momentum from its strong second-quarter 2026 earnings report.

  • Adjusted earnings reached $9.38 per share versus an expected $4.88, while revenue slightly missed forecasts.
  • Shares reportedly reached a 52-week high of $204.26 on September 14, 2026.
  • The cybersecurity disclosure was published September 10–11; no new September 14 catalyst was identified.